BIGMAR INC
10QSB, EX-27.1, 2000-11-14
PHARMACEUTICAL PREPARATIONS
Previous: BIGMAR INC, 10QSB, 2000-11-14
Next: ZEROPLUS COM INC, 10QSB, 2000-11-14



<TABLE> <S> <C>

<ARTICLE> 5
<CIK> 0001012466
<NAME> BIGMAR, INC.

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                         105,737
<SECURITIES>                                         0
<RECEIVABLES>                                1,796,061
<ALLOWANCES>                                         0
<INVENTORY>                                  2,270,754
<CURRENT-ASSETS>                             4,480,155
<PP&E>                                      17,744,188
<DEPRECIATION>                               5,236,264
<TOTAL-ASSETS>                              17,294,546
<CURRENT-LIABILITIES>                        7,443,238
<BONDS>                                     10,266,589
                                0
                                          0
<COMMON>                                        10,169
<OTHER-SE>                                     157,354
<TOTAL-LIABILITY-AND-EQUITY>                17,294,546
<SALES>                                      5,823,345
<TOTAL-REVENUES>                             5,823,345
<CGS>                                        4,721,822
<TOTAL-COSTS>                                4,633,719
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             706,974
<INCOME-PRETAX>                            (3,995,854)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (3,995,854)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                361,837
<CHANGES>                                            0
<NET-INCOME>                               (3,634,017)
<EPS-BASIC>                                     (0.38)
<EPS-DILUTED>                                   (0.38)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission